Harvard Bioscience Inc (HBIO): HBIO on watch for secondary offering:...

Replies (1) Next 10 Prev Next

surf1944

Send PM Follow Ignore

Followers	467
Posts	26957
Boards Moderated	1
Alias Born	09/11/2006

surf1944

Re: surf1944 post# 7

Sunday, 04/15/2012 7:35:08 PM

Sunday, April 15, 2012 7:35:08 PM

HBIO on watch for secondary offering:

Total Cash (mrq): 17.92M
Total Cash Per Share (mrq): 0.62
Total Debt (mrq): 16.30M
Total Debt/Equity (mrq): 17.07
Current Ratio (mrq): 6.02
Book Value Per Share (mrq): 3.35

surf's up......crikey

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent HBIO News

Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/27/2026 11:30:21 AM
Sidoti Events, LLC's May Micro-Cap Virtual Conference • ACCESS Newswire • 05/20/2026 11:30:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:30:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 11:30:20 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 11:30:18 AM
Harvard Bioscience Announces First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/12/2026 11:30:00 AM
Harvard Bioscience to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2026 11:30:00 AM
Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET • GlobeNewswire Inc. • 04/28/2026 11:30:00 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2026 08:58:07 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/21/2026 08:56:34 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 01:57:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 01:44:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 01:48:04 PM
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 03/23/2026 12:00:21 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 06:13:07 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:31:56 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 09:56:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 11:30:12 AM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/13/2026 12:20:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 11:30:29 AM
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results • GlobeNewswire Inc. • 03/12/2026 11:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 11:30:26 AM
Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 09:01:29 PM
Harvard Bioscience Announces Reverse Stock Split • GlobeNewswire Inc. • 03/06/2026 09:01:00 PM
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent HBIO News

More HBIO News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent HBIO News

Go Ad-Free